Kate Knibbs

While big platforms like Reddit have signed deals with the AI giants, YouTube leaves licensing in the hands of individual creators. The “License to Scrape” program aims to give those streaming stars proper leverage.

OpenAI’s spree of licensing agreements is paying off already—at least in terms of getting publishers to lower their guard.

Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded versions of these GLP-1 medications, it’s a complicated situation.

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” versions of its meds.

In a new copyright lawsuit against AI startup Perplexity, Dow Jones and the New York Post argue that hallucinating fake news and attributing it to real papers is illegal.

The blogging platform Medium is facing an influx of AI-generated content. CEO Tony Stubblebine says it “doesn’t matter” as long as nobody reads it.

An SEO agency owner says he is “very depressed” after one of his AI-assisted Halloween parade listings misled revelers in Dublin, Ireland.

Prediction markets like Kalshi beat pollsters in forecasting the 2024 US election. Mansour now says financial marketplaces are the future of political prognostication.

A judge tossed out a case against OpenAI brought by Alternet and Raw Story, in what could be a significant ruling in the larger battle between AI companies and publishers.

An analysis of Substack’s top newsletters estimated that around 10 percent publish AI-generated or AI-assisted content.